non-severe COVID-19
Showing 1 - 25 of >10,000
Covid-19 Trial in Mexico City (Estrogen Therapy)
Active, not recruiting
- Covid-19
- Estrogen Therapy
-
Mexico City, Benito Juárez, MexicoCMN "20 de Noviembre"
Jul 7, 2022
Disease Outcomes in Non-severe COVID-19 Patient
Recruiting
- COVID-19 Patient
-
Shanghai, Shanghai, ChinaRuijin Hospital affiliated to Shanghai Jiao Tong University Scho
Aug 4, 2022
Japan After Severe Acute Respiratory Syndrome Coronavirus 2
Not yet recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd
Jun 6, 2023
COVID-19 Trial in Budapest (Extracorporeal photopheresis)
Recruiting
- COVID-19
- Extracorporeal photopheresis
-
Budapest, HungarySouth Pest Central Hospital, National Institute of Haematology a
May 28, 2023
Deep Venous Thrombosis in Non-severe COVID-19 Patients
Completed
- Deep Venous Thrombosis
-
Strasbourg, FranceService Unité Neurovasculaire
Oct 7, 2021
Post COVID-19 Neurologic Symptoms :Somatic Spectrum Disorder ?
Completed
- COVID-19
-
Saint-denis, Ile De France, FranceCentre Hospitalier de Saint-Denis
Feb 9, 2022
Sars-cov-2 Trial in Sulaymaniyah (Xagrotin, Green tea)
Not yet recruiting
- Sars-cov-2
- Xagrotin
- Green tea
-
Sulaymaniyah, IraqDirectorate of health of Sulaimani, Iraq -KRG
Mar 2, 2022
COVID-19 Trial in Wuhan (Postural interventions based on pulmonary imaging)
Recruiting
- COVID-19
- Postural interventions based on pulmonary imaging
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Jan 11, 2023
Severe COVID-19 Infection in CLL or B-NHL Who Received
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- (no location specified)
Apr 6, 2023
Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide
Recruiting
- Covid19
- +3 more
- Nitazoxanide and Ciclésonide
- +3 more
-
Bobo-Dioulasso, Burkina Faso
- +1 more
Jan 30, 2023
COVID-19 Trial in São Paulo (Hydroxychloroquine Sulfate, Azithromycin Tablets)
Suspended
- COVID-19
- Hydroxychloroquine Sulfate
- Azithromycin Tablets
-
São Paulo, BrazilPrevent Senior Private Operadora de Saúde LTDA.
Nov 3, 2022
Covid19 Trial in Kampala (Hydroxychloroquine tablets)
Active, not recruiting
- Covid19
- Hydroxychloroquine tablets
-
Kampala, UgandaNamboole COVID-19 treatment unit
Apr 23, 2021
COVID-19 Serologic and Virologic Testing to Accelerate Recovery
Withdrawn
- Covid19
- SARS-CoV Infection
-
Lexington, KentuckyUniversity of Kentucky
Sep 9, 2022
COVID-19 Trial (PF-07321332 (nirmatrelvir)/ritonavir)
Not yet recruiting
- COVID-19
- PF-07321332 (nirmatrelvir)/ritonavir
- (no location specified)
Aug 2, 2022
COVID-19 Trial in Mexico City (Maraviroc + Currently used therapy, Curently used therapy for COVID-19 non-critical patients,
Terminated
- COVID-19
- Maraviroc + Currently used therapy
- +3 more
-
Mexico City, Cdmx, MexicoHospital General de México "Dr. Eduardo Liceaga"
May 31, 2022
Non-invasive Oxygenation Strategies in Patients Admitted for
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Use of High Flow Nasal Cannula alone
- +2 more
-
Béthune, Nord-Pas-de-Calais, France
- +3 more
Oct 10, 2022
Non-invasive Respiratory Support on Outcome and Its Risks in
Active, not recruiting
- COVID-19
- Hypoxemic Respiratory Failure
- High flow nasal oxygen (HFNO, more than 15 L/min)
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Sep 4, 2023
COVID-19 Infection Trial in Taichung (Allogeneic umbilical cord mesenchymal stem cells, Controlled normal saline)
Active, not recruiting
- COVID-19 Infection
- Allogeneic umbilical cord mesenchymal stem cells
- Controlled normal saline
-
Taichung, Non-US, TaiwanChina Medical University Hospital
Aug 11, 2022
COVID-19 Pneumonia Trial in Peshawar (Unfractionated heparin)
Not yet recruiting
- COVID-19 Pneumonia
- Unfractionated heparin
-
Peshawar, Khyber Pakhtunkhwa, PakistanPulmonology Department, Lady Reading Hospital, Peshawar
Apr 23, 2022
Covid19 Trial in Manila (Favipiravir + Standard of Care, Standard of Care)
Recruiting
- Covid19
- Favipiravir + Standard of Care
- Standard of Care
-
Manila, National Capital Region, PhilippinesDr. Regina Berba
Aug 19, 2021
Post-COVID-19 Syndrome Trial in Istanbul (non-invasive auricular vagus stimulation, Placebo Non Invasive Vagus Stimulation)
Recruiting
- Post-COVID-19 Syndrome
- non-invasive auricular vagus stimulation
- Placebo Non Invasive Vagus Stimulation
-
Istanbul, Istanbul Avrupa Kitasi, TurkeyBahçeşehir University
Mar 10, 2023
Severe to Critical COVID 19 With Associated ARDS Trial in United States (FP-025 100 mg, FP-025 300 mg, Placebo)
Terminated
- Severe to Critical COVID 19 With Associated ARDS
- FP-025 100 mg
- +2 more
-
Chula Vista, California
- +7 more
Aug 4, 2022
Covid19 Trial in Monastir (Vit-D 0.2 MG/ML Oral Solution [Calcidol], Physiological Irrigating Solution)
Completed
- Covid19
- Vit-D 0.2 MG/ML Oral Solution [Calcidol]
- Physiological Irrigating Solution
-
Monastir, TunisiaAsma Sriha Belguit
May 10, 2021